The Overall Health of the MedTech Industry

This chapter explores the overall health of the MedTech industry, discussing revenue growth, R&D spending, and shareholder returns as indicators of its thriving state. However, it also highlights the financing challenges faced by the industry, such as declines in equity financing, VC investment, and M&A activities. The chapter also examines the prevalence of successful spin-offs and the decrease in IPOs, as well as the embrace of AI in the industry and the role it plays in managing healthcare data.